KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
07 2019
Historique:
received: 07 05 2019
accepted: 11 05 2019
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 14 5 2020
Statut: ppublish

Résumé

A recurrent de novo missense variant in KCNC1, encoding a voltage-gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 in five unrelated individuals causing different phenotypes featuring either isolated nonprogressive myoclonus (p.Cys208Tyr), intellectual disability (p.Thr399Met), or epilepsy with myoclonic, absence and generalized tonic-clonic seizures, ataxia, and developmental delay (p.Ala421Val, three patients). Functional analyses demonstrated no measurable currents for all identified variants and dominant-negative effects for p.Thr399Met and p.Ala421Val predicting neuronal disinhibition as the underlying disease mechanism.

Identifiants

pubmed: 31353862
doi: 10.1002/acn3.50799
pmc: PMC6649617
doi:

Substances chimiques

Codon, Nonsense 0
KCNC1 protein, human 0
Shaw Potassium Channels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1319-1326

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : FOR-2715
Pays : International
Organisme : University of Tuebingen
Pays : International
Organisme : Bundesministerium für Bildung und Forschung
ID : FKZ 01GM1907A
Pays : International
Organisme : Bundesministerium für Bildung und Forschung
ID : FKZ 01ZX1405C
Pays : International
Organisme : intramural fortüne program
ID : #
Pays : International
Organisme : intramural fortüne program
ID : 2435-0-0
Pays : International

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Neurology. 2014 Feb 4;82(5):405-11
pubmed: 24384641
Trends Neurosci. 2001 Sep;24(9):517-26
pubmed: 11506885
Genet Med. 2016 Sep;18(9):898-905
pubmed: 26795593
Hum Genet. 2018 May;137(5):401-411
pubmed: 29796876
Ann Clin Transl Neurol. 2019 Jul;6(7):1319-1326
pubmed: 31353862
Eur J Pharmacol. 2018 Aug 15;833:255-262
pubmed: 29894724
Nat Neurosci. 2005 Oct;8(10):1335-42
pubmed: 16136041
Brain Dev. 2018 May;40(5):429-432
pubmed: 29428275
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
PLoS One. 2015 Mar 10;10(3):e0116599
pubmed: 25756792
Neuron. 1996 Jun;16(6):1169-77
pubmed: 8663993
Res Dev Disabil. 2011 Mar-Apr;32(2):419-36
pubmed: 21236634
PLoS One. 2011 Mar 29;6(3):e17811
pubmed: 21479265
Nat Genet. 2018 Jul;50(7):1048-1053
pubmed: 29942082
Eur J Hum Genet. 2017 May;25(5):560-564
pubmed: 28145425
Ment Retard Dev Disabil Res Rev. 2002;8(3):117-34
pubmed: 12216056
PLoS One. 2017 Nov 30;12(11):e0188978
pubmed: 29190809
Brain. 2013 Jun;136(Pt 6):1708-17
pubmed: 23687123
Nat Genet. 2015 Jan;47(1):39-46
pubmed: 25401298
Epilepsia. 2000 Jul;41(7):802-10
pubmed: 10897150
Lancet. 2012 Nov 10;380(9854):1674-82
pubmed: 23020937
Ann Neurol. 2017 May;81(5):677-689
pubmed: 28380698

Auteurs

Joohyun Park (J)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Mahmoud Koko (M)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Ulrike B S Hedrich (UBS)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Andreas Hermann (A)

Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology and Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.
German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147, Rostock, Germany.

Kirsten Cremer (K)

Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

Edda Haberlandt (E)

Clinic for Pediatrics, Krankenhaus Stadt Dornbirn, Dornbirn, Austria.

Mona Grimmel (M)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Bader Alhaddad (B)

Institute of Human Genetics, Technische Universität München, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Stefanie Beck-Woedl (S)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Merle Harrer (M)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Daniela Karall (D)

Clinic for Pediatrics, Division of Inherited Metabolic Disorders, Medical University of Innsbruck, Innsbruck, Austria.

Lisa Kingelhoefer (L)

Department of Neurology, Technische Universität Dresden and German Center for Neurodegenerative Diseases, Research Side Dresden, Dresden, Germany.

Andreas Tzschach (A)

Institute of Clinical Genetics, Technische Universität Dresden, Dresden, Germany.

Lars C Matthies (LC)

Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

Tim M Strom (TM)

Institute of Human Genetics, Technische Universität München, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Erich Bernd Ringelstein (EB)

Department of Neurology, University Hospital of Muenster, Muenster, Germany.
German Neuroscience Center, Dubai, United Arab Emirates.

Marc Sturm (M)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Hartmut Engels (H)

Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

Markus Wolff (M)

Department of Neuropediatrics, University of Tübingen, Tübingen, Germany.

Holger Lerche (H)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Tobias B Haack (TB)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.
Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH